FDA seeing one of slowest years for new drug approvals in five years

08/7/2008 | CNNMoney

The FDA cleared nine drugs by the end of June, putting it on track to authorize 18 "new molecular entities" -- treatments with active ingredients that are not found in other approved therapies -- this year. An agency spokeswoman said approvals in the second half of 2008 will depend on new-drug applications, which "come in on a rolling basis." Twenty-two such drugs were approved in 2006.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Meridian Health Plan
Detroit, MI